These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 31503175)

  • 21. Remote "hovering" with individuals with psychotic disorders and substance use: feasibility, engagement, and therapeutic alliance with a text-messaging mobile interventionist.
    Ben-Zeev D; Kaiser SM; Krzos I
    J Dual Diagn; 2014; 10(4):197-203. PubMed ID: 25391277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Online, social media and mobile technologies for psychosis treatment: a systematic review on novel user-led interventions.
    Alvarez-Jimenez M; Alcazar-Corcoles MA; González-Blanch C; Bendall S; McGorry PD; Gleeson JF
    Schizophr Res; 2014 Jun; 156(1):96-106. PubMed ID: 24746468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and usability testing of FOCUS: a smartphone system for self-management of schizophrenia.
    Ben-Zeev D; Kaiser SM; Brenner CJ; Begale M; Duffecy J; Mohr DC
    Psychiatr Rehabil J; 2013 Dec; 36(4):289-296. PubMed ID: 24015913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing early signs of relapse in psychosis: review and future directions.
    Eisner E; Drake R; Barrowclough C
    Clin Psychol Rev; 2013 Jul; 33(5):637-53. PubMed ID: 23628908
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of two delivery modalities of a mobile phone-based assessment for serious mental illness: native smartphone application vs text-messaging only implementations.
    Ainsworth J; Palmier-Claus JE; Machin M; Barrowclough C; Dunn G; Rogers A; Buchan I; Barkus E; Kapur S; Wykes T; Hopkins RS; Lewis S
    J Med Internet Res; 2013 Apr; 15(4):e60. PubMed ID: 23563184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating mobile-phone based assessment for psychosis into people's everyday lives and clinical care: a qualitative study.
    Palmier-Claus JE; Rogers A; Ainsworth J; Machin M; Barrowclough C; Laverty L; Barkus E; Kapur S; Wykes T; Lewis SW
    BMC Psychiatry; 2013 Jan; 13():34. PubMed ID: 23343329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of treatment response in second-episode versus first-episode schizophrenia.
    Emsley R; Oosthuizen P; Koen L; Niehaus D; Martinez L
    J Clin Psychopharmacol; 2013 Feb; 33(1):80-3. PubMed ID: 23277247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mobile technologies among people with serious mental illness: opportunities for future services.
    Ben-Zeev D; Davis KE; Kaiser S; Krzsos I; Drake RE
    Adm Policy Ment Health; 2013 Jul; 40(4):340-3. PubMed ID: 22648635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Service availability and utilization and treatment gap for schizophrenic disorders: a survey in 50 low- and middle-income countries.
    Lora A; Kohn R; Levav I; McBain R; Morris J; Saxena S
    Bull World Health Organ; 2012 Jan; 90(1):47-54, 54A-54B. PubMed ID: 22271964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mobile Assessment and Treatment for Schizophrenia (MATS): a pilot trial of an interactive text-messaging intervention for medication adherence, socialization, and auditory hallucinations.
    Granholm E; Ben-Zeev D; Link PC; Bradshaw KR; Holden JL
    Schizophr Bull; 2012 May; 38(3):414-25. PubMed ID: 22080492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a psychosocial intervention for relapse prevention in patients with schizophrenia receiving risperidone via long-acting injection.
    Lee SH; Choi TK; Suh S; Kim YW; Kim B; Lee E; Yook KH
    Psychiatry Res; 2010 Feb; 175(3):195-9. PubMed ID: 20022120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disengagement from mental health treatment among individuals with schizophrenia and strategies for facilitating connections to care: a review of the literature.
    Kreyenbuhl J; Nossel IR; Dixon LB
    Schizophr Bull; 2009 Jul; 35(4):696-703. PubMed ID: 19491314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation.
    Briggs A; Wild D; Lees M; Reaney M; Dursun S; Parry D; Mukherjee J
    Health Qual Life Outcomes; 2008 Nov; 6():105. PubMed ID: 19040721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of mental disorders.
    Eaton WW; Martins SS; Nestadt G; Bienvenu OJ; Clarke D; Alexandre P
    Epidemiol Rev; 2008; 30():1-14. PubMed ID: 18806255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Information Technology Aided Relapse Prevention Programme in Schizophrenia: an extension of a mirror-design follow-up.
    Spaniel F; Vohlídka P; Kozený J; Novák T; Hrdlicka J; Motlová L; Cermák J; Höschl C
    Int J Clin Pract; 2008 Dec; 62(12):1943-6. PubMed ID: 18795967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ITAREPS: information technology aided relapse prevention programme in schizophrenia.
    Spaniel F; Vohlídka P; Hrdlicka J; Kozený J; Novák T; Motlová L; Cermák J; Bednarík J; Novák D; Höschl C
    Schizophr Res; 2008 Jan; 98(1-3):312-7. PubMed ID: 17920245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.
    van Haren NE; Hulshoff Pol HE; Schnack HG; Cahn W; Mandl RC; Collins DL; Evans AC; Kahn RS
    Neuropsychopharmacology; 2007 Oct; 32(10):2057-66. PubMed ID: 17327887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An intervention study to prevent relapse in patients with schizophrenia.
    van Meijel B; Kruitwagen C; van der Gaag M; Kahn RS; Grypdonck MH
    J Nurs Scholarsh; 2006; 38(1):42-9. PubMed ID: 16579323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A program for relapse prevention in schizophrenia: a controlled study.
    Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
    Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.
    Robinson D; Woerner MG; Alvir JM; Bilder R; Goldman R; Geisler S; Koreen A; Sheitman B; Chakos M; Mayerhoff D; Lieberman JA
    Arch Gen Psychiatry; 1999 Mar; 56(3):241-7. PubMed ID: 10078501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.